Cited by 50Economic and Financial Impacts of CancerHealthcare Systems and ReformsHealth Systems, Economic Evaluations, Quality of Life

Cost of Treatment for Cervical Cancer in India

Open access
Singh, Maninder Pal, Chauhan, Akashdeep, Rai, Bhavana, Ghoshal, Sushmita, Prinja, Shankar·2020·Asian Pacific Journal of Cancer Prevention

Abstract

INTRODUCTION: Cervical cancer is a major public health problem in India leading to high economic burden, which is disproportionately borne by the patients as out-of-pocket expenditure (OOPE). Several publicly financed health insurance schemes (PFHIs) in India cover the treatment for cervical cancer. However, the provider payment rates for health benefit packages (HBP) under these PFHIs are not based on scientific evidence. We undertook this study to estimate the cost of services provided for treatment of cervical cancer and cost of the package of care for cervical cancer in India. METHODS: The study was undertaken at a large public tertiary hospital in North India. The health system cost was assessed using a mixed micro-costing approach. The data were collected for all the resources utilized during service delivery for cervical cancer patients. To evaluate the OOPE, randomly selected 248 patients were interviewed following the cost of illness approach. Logistic regression was used to assess the factors associated with catastrophic health expenditure (CHE). RESULTS: Health system cost for different cervical cancer treatment modalities i.e. radiotherapy, brachytherapy, chemotherapy and surgery, ranges from INR 19,494 to 41,388 (USD 291 - 617). Furthermore, patients spent INR 4,042 to 23,453 ( USD 60 - 350) as OOPE. Nearly 62% patients incurred CHE, and 30% reported distress financing. The odds of CHE (OR: 25.39, p-value: <0.001) and distress financing (OR: 15.37, p-value: 0.001) were significantly higher in poorest-income quintile. The HBP cost varies from INR 45,364 to 64,422 (USD 676 - 960) for brachytherapy and radiotherapy respectively. CONCLUSION: Cervical cancer treatment leads to high OOPE in India, which imposes financial hardship, especially for the poorest. The coverage of risk pooling mechanisms like PHFIs should be enhanced. The findings of our study should be used to set the reimbursement rates of providing cervical cancer treatment under PFHI schemes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.31557/apjcp.2020.21.9.2639

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cost of treatment for cervical cancer was based on primary data collected from a large public sector tertiary care hospital in North India for 2016-17.

    “The cost of treatment for cervical cancer was based on the primary data collected from a large public sector tertiary care hospital in North India for the year 2016–17. [38]”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 24

  1. Alam K Mahal A Economic impacts of health shocks on households in low and middle income countries: a review of the literature Global Health 2014 10 21 24708831 PMC4108100
  2. Angell BJ Prinja S Gupt A Jha V Jan S The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana and the path to universal health coverage in India: Overcoming the challenges of stewardship and governance PLoS Med 2019 16 e1002759 30845199 PMC6405049
  3. Arbyn M Weiderpass E Bruni L et al Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis Lancet Globl Health 2020 8 191 203 PMC7025157 31812369
  4. Bobdey S Sathwara J Jain A Balasubramaniam G Burden of cervical cancer and role of screening in India Indian J Med Paediatr Oncol 2016 37 278 85 28144096 PMC5234166
  5. Bray F Ren JS Masuyer E Ferlay J Global estimates of cancer prevalence for 27 sites in the adult population in 2008 Int J Cancer 2013 132 1133 45 22752881
  6. Kimman M Jan S Yip CH Catastrophic health expenditure and 12-month mortality associated with cancer in Southeast Asia: results from a longitudinal study in eight countries BMC Med 2015 13 190 26282128 PMC4539728
  7. Chapko MK Liu CF Perkins M 2009) Equivalence of two healthcare costing methods: bottom-up and top-down Health Econ 18 1188 1201 19097041
  8. Chatterjee S Levin C Laxminarayan R Unit cost of medical services at different hospitals in India PLoS One 2013 8 e69728 23936088 PMC3720595
  9. Chauhan AS Prinja S Ghoshal S Verma R Oinam AS Cost of treatment for head and neck cancer in India PLoS One 2018 13 e0191132 29324861 PMC5764364
  10. Ferlay J Soerjomataram I Dikshit R Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 2015 2015 359 86 25220842
  11. Huffman M Rao K Pichon-Riviere A A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low-and middle-income countries PLoS One 2011 6 e20821 21695127 PMC3114849
  12. Kankeu HT Saksena P Xu K Evans DB The financial burden from non-communicable diseases in low- and middle-income countries: a literature review Health Res Policy Syst 2013 11 31 23947294 PMC3751656
  13. Mahal A Karan A Fan VY Engelgau M The economic burden of cancers on Indian households PLoS One 2013 8 e71853 23951258 PMC3741186
  14. Moreno-Serra R Millett C Smith PC Towards improved measurement of financial protection in health PLoS Med 2011 8 8 13 PMC3167798 21909246
  15. Prinja S Chauhan AS Rajsekhar K Addressing the Cost Data Gap for Universal Health Care Coverage in India: A National Health System Cost Database for India Value in Health Regional Issues 2020a 21 pp 226 9 32330864
  16. Prinja S Singh MP Guinness L Rajsekhar K Bhargava B Establishing reference costs for the health benefit packages under universal health coverage in India: cost of health services in India (CHSI) protocol BMJ Open 2020b 10 e035170 PMC7375634 32690737
  17. Prinja S Kaur G Gupta R Rana SK Aggarwal AK Out of Pocket Expenditure for Health Care: District Level Estimates for Haryana State in India Int J Health Plann Manage 2019 34 277 93 30113728
  18. Prinja S Chauhan AS Karan A Kaur G Kumar R Impact of publicly financed health insurance schemes on healthcare utilization and financial risk protection in India: A Systematic Review PLoS One 2017a 12 e0170996 28151946 PMC5289511
  19. Prinja S Bahuguna P Faujdar DS Cost Effectiveness of HPV Vaccination for Adolescent Girls in Punjab State: Implications for India’s UIP Program Cancer 2017c 123 3253 60 28472550
  20. Prinja S Jagnoor J Chauhan AS Economic burden of hospitalization due to injuries in North India: A Cohort Study Int J Environ Res Public Health 2016 13 673 PMC4962214 27384572
  21. Prinja S Jeet G Verma R Economic analysis of delivering primary health care services through community health workers in 3 North Indian States PLoS One 2014 13 e91781 PMC3953597 24626285
  22. Rajpal S Kumar A Joe W Economic burden of cancer in India: Evidence from cross-sectional nationally representative household survey, 2014 PLoS One 2018 13 e0193320 29481563 PMC5826535
  23. Rice DP Cost of illness studies: What is good about them? Inj Prev 2000 6 177 9 11003181 PMC1730654
  24. Sangwan A Prinja S Aggarwal S Cost of trauma care in secondary- and tertiary-care public sector Hospitals in North India Appl Health Econ Health Policy 2017 15 681 92 28409489

Cited by

Sorted by citations

Authors
Singh, M. P., Chauhan, A., Rai, B., Ghoshal, S., & Prinja, S.
Affiliations
Post Graduate Institute of Medical Education and Research (IN)
Corresponding author
Prinja, Shankar
Venue
Asian Pacific Journal of Cancer Prevention
Published
2020-09-01
Volume
21
Issue
9
Pages
2639-2646
ISSN
  • 1513-7368 (ISSN-L)
  • 2476-762X
OpenAlex
W3089813054
Cited by
50
References
2
Citations by year
2026: 7 · 2025: 5 · 2024: 11 · 2023: 11 · 2022: 10 · 2021: 4 · 2020: 2
FWCI
5.74
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Asian Pacific Journal of Cancer Prevention (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
Funders
Ministry of Health and Family Welfare
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
  • Social Sciences › Economics, Econometrics and Finance › Finance › Healthcare Systems and Reforms
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
cervical cancer, treatment costs, out-of-pocket costs, catastrophic health expenditure, distress financing, health benefits package, radiotherapy, brachytherapy, economic burden, financial hardship, poverty, India
MeSH terms
Uterine Cervical Neoplasms, Delivery of Health Care, Health Expenditures, Female, Financing, Personal, Follow-Up Studies, Hospitalization, Humans, Income, India, Middle Aged, Prognosis, Prospective Studies, Retrospective Studies, Socioeconomic Factors, Health Care Costs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review